RxDoctor Payments Data

Anushirvan Minokadeh, MD

Critical Care Medicine · San Diego, CANPI 1053339093

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,450 of the $33,318 with a category attached, or 91.4%. AstraZeneca accounts for 96.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $29,333 and has fallen 99.4% since, to $168 in 2025. Among critical care medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,318in general payments, 2019–2025

Across 48 payments — averaging $694.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$32K
  • Masimo Corporation$750
  • Johnson & Johnson$125
  • Bayer$125
  • ZOLL Medical Corporation$82
  • Daiichi Sankyo Inc.$74
  • plus $62 from 2 others

What the payments were for

  • Speaking & faculty fees$30,45091%
  • Travel & lodging$7992%
  • Food & beverage$2,0706%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca41$32,100
Masimo Corporation1$750
Johnson & Johnson1$125
Bayer1$125
ZOLL Medical Corporation1$82
Daiichi Sankyo Inc.1$74
Baxter Healthcare1$47
Medivance, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,318 in reported general payments places this provider in the 95th percentile of 715 critical care medicine providers in California.

See all critical care medicine providers in California

Medicare billing

Part B allowed, 2024
$58,872
Medicare patients
162
Services billed
406

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →